GUANOSINE 5'-O-(2-THIODIPHOSPHATE) TRILITHIUM SALT
![]() |
- ₹18077.75 - ₹49351.18
- Product name: GUANOSINE 5'-O-(2-THIODIPHOSPHATE) TRILITHIUM SALT
- CAS: 97952-36-8
- MF: C10H12Li3N5O10P2S
- MW: 477.07
- EINECS:308-328-9
- MDL Number:MFCD00057735
- Synonyms:GDP-BETA-S TRILITHIUM SALT;GDP-BETA-S 3LI;GDP-BETA-S TRILITHIUM;GDP-BETA-S-LI3;GUANOSINE 5'-[BETA-THIO]DIPHOSPHATE TRILITHIUM SALT;GUANOSINE-5'-O-(2-THIODIPHOSPHATE) TRILITHIUM;GUANOSINE-5'-O-(2-THIODIPHOSPHORIC ACID), TRILITHIUM;GUANOSINE 5'-O-(2-THIODIPHOSPHATE) TRILITHIUM SALT
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberG7637
- Product descriptionGuanosine 5′-[β-thio]diphosphate trilithium salt ≥85% (HPLC), powder
- Packaging5MG
- Price₹18077.75
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberG7637
- Product descriptionGuanosine 5′-[β-thio]diphosphate trilithium salt ≥85% (HPLC), powder
- Packaging25MG
- Price₹49351.18
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | G7637 | Guanosine 5′-[β-thio]diphosphate trilithium salt ≥85% (HPLC), powder | 5MG | ₹18077.75 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | G7637 | Guanosine 5′-[β-thio]diphosphate trilithium salt ≥85% (HPLC), powder | 25MG | ₹49351.18 | 2022-06-14 | Buy |
Properties
storage temp. :-20°C
solubility :H2O: soluble20mg/mL (Solutions are very unstable; prepare immediately prior to use.)
form :powder
color :white
Water Solubility :water: 50mg/mL
BRN :8181243
solubility :H2O: soluble20mg/mL (Solutions are very unstable; prepare immediately prior to use.)
form :powder
color :white
Water Solubility :water: 50mg/mL
BRN :8181243
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|